Clinical Research Directory
Browse clinical research sites, groups, and studies.
Biomarkers in Predicting Treatment Response in Samples From Patients With Early-Stage Non-Small Cell Lung Cancer Previously Treated With Adjuvant Chemotherapy
Sponsor: National Cancer Institute (NCI)
Summary
This research trial studies biomarkers in predicting treatment response in samples from patients with early-stage non-small cell lung cancer previously treated with adjuvant chemotherapy. Studying samples of tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. It may also help doctors predict how patients will respond to treatment.
Official title: The Identification, Validation and Implemention of Prognostic and/or Predictive Biomarkers for Adjuvant Chemotherapy in Early Stage Non-Small Cell Lung Cancer (NSCLC)
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
950
Start Date
2012-05
Completion Date
Not specified
Last Updated
2013-09-20
Healthy Volunteers
No
Conditions
Interventions
medical chart review
Correlative studies
laboratory biomarker analysis
Correlative studies
Locations (1)
National Cancer Institute of Canada Clinical Trials Group
Kingston, Ontario, Canada